<DOC>
	<DOCNO>NCT01365806</DOCNO>
	<brief_summary>The long-term goal research apply novel technology detection donor organ ( allograft ) rejection improve patient outcomes follow heart transplantation . The specific goal study determine whether daily monitoring transplant recipient 's electrocardiogram ( ECG ) use simple home device transmission ECG Core Laboratory would provide early biomarker acute rejection . Despite routine immunosuppressant drug therapy , acute rejection common , especially within first 6 month follow transplant surgery . To detect rejection , frequent endomyocardial biopsy heart tissue perform . An endomyocardial biopsy costly invasive procedure perform hospital cardiac catheterization laboratory associate risk . Recent evidence suggest acute allograft rejection cause delay ventricular repolarization result long QT interval ECG . The specific aim study : 1 ) determine whether increase QT interval first 6 month follow heart transplant sensitive specific biomarker acute rejection ; 2 ) determine time QT interval increase relative biopsy-diagnosed stage mild/moderate/severe rejection . The potential benefit find simple ECG biomarker allograph rejection could measure home might yield early detection rejection , allow timely therapy reduce mortality acute allograft rejection .</brief_summary>
	<brief_title>Home Electrocardiogram ( ECG ) Monitoring After Heart Transplantation</brief_title>
	<detailed_description />
	<criteria>â‰¥18 year age first heart transplant surgery enrol research study conflict study design clinically unstable time enrollment ( i.e . clinical symptom allograph impairment )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>heart transplantation</keyword>
	<keyword>allograft rejection</keyword>
	<keyword>QT interval</keyword>
	<keyword>electrocardiogram ( ECG )</keyword>
</DOC>